![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 10, 5892-5902, March 6, 1998
From the Center for Gerontology, Allegheny University of the Health
Sciences and the Division of Rheumatology, Department of Medicine,
University of Pennsylvania, Philadelphia, Pennsylvania 19104
Activating transcription factor
2 (ATF2) is regulated by phosphorylation via the Jun N-terminal kinase,
and its binding activity is markedly induced at late stages of T and B
lymphocyte activation (Feuerstein, N., Firestein, R., Aiyer, N.,
Xiao, H., Murasko, D., and Cristofalo, V. (1996)
J. Immunol. 156, 4582-4593). To identify proteins
that interact specifically with ATF2 in lymphocytes, the yeast
two-hybrid interaction system was employed using ATF2 cDNA as a
"bait." In two separate screenings, a clone was identified that
revealed a novel sequence with homology to several members of the
ubiquitin-conjugating enzyme family. An identical sequence was recently
reported as the human homolog of the yeast UBC9, hUBC9. Northern blot
analysis revealed a 1.3-kilobase RNA transcript, which showed
differential levels of expression in various human tissues and a
moderate induction after a 48-h stimulation of peripheral blood T
lymphocytes. An antibody that was generated against the bacterially
expressed glutathione S-transferase-hUBC9 detected a
~19-kDa protein, which localizes predominantly in the nuclei of T
cells. Further quantitative assays using the yeast two-hybrid system
confirmed a high and specific level of interaction of hUBC9 with ATF2
and lack of interaction with lamin or control vectors. Two other cyclic
AMP-responsive element-binding transcription factors, CREB and ATF1,
also showed significant levels of interaction with hUBC9. However, this
interaction was severalfold lower as compared with ATF2. Far Western
blot analysis confirmed the specific binding of ATF2 and hUBC9 also
in vitro. Evidence is presented that indicates a
physiological significance for the interaction of hUBC9 with ATF2.
(a) We show that ATF2 is ubiquitinated in vivo
and in vitro, and (b) ATF2 ubiquitination
in vitro is facilitated by addition of purified hUBC9.
(c) ATF2 is shown to undergo a proteolytic process, which
is rapidly regulated upon T cell activation concomitant with induction
of ATF2 phosphorylation. (d) A proteasome inhibitor delays
the down-regulation of ATF2 phophorylation after T cell activation.
Taken collectively, these results implicate a role for hUBC9 and the
ubiquitin/proteasome pathway in regulation of ATF2 in T cells.
Association of Activating Transcription Factor 2 (ATF2) with the
Ubiquitin-conjugating Enzyme hUBC9
IMPLICATION OF THE UBIQUITIN/PROTEASOME PATHWAY IN REGULATION OF
ATF2 IN T CELLS
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Bhoumik, N. Singha, M. J. O'Connell, and Z. A. Ronai Regulation of TIP60 by ATF2 Modulates ATM Activation J. Biol. Chem., June 20, 2008; 283(25): 17605 - 17614. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Lawrence, H. Maekawa, J. L. Worthington, W. Reiter, C. R. M. Wilkinson, and N. Jones Regulation of Schizosaccharomyces pombe Atf1 Protein Levels by Sty1-mediated Phosphorylation and Heterodimerization with Pcr1 J. Biol. Chem., February 23, 2007; 282(8): 5160 - 5170. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gaikwad, A. Poblenz, V. Haridas, C. Zhang, M. Duvic, and J. Gutterman Triterpenoid Electrophiles (Avicins) Suppress Heat Shock Protein-70 and X-Linked Inhibitor of Apoptosis Proteins in Malignant Cells by Activation of Ubiquitin Machinery: Implications for Proapoptotic Activity Clin. Cancer Res., March 1, 2005; 11(5): 1953 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sevilla, C. R. Santos, F. M. Vega, and P. A. Lazo Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK J. Biol. Chem., June 25, 2004; 279(26): 27458 - 27465. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Feuerstein, D. Shivers, F. Chen, R. A. Eisenberg, and T. H. Finkel Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors Int. Immunol., August 1, 2003; 15(8): 975 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Comerford, M. O. Leonard, J. Karhausen, R. Carey, S. P. Colgan, and C. T. Taylor Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia PNAS, February 4, 2003; 100(3): 986 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Saitoh, M. D. Pizzi, and J. Wang Perturbation of SUMOlation Enzyme Ubc9 by Distinct Domain within Nucleoporin RanBP2/Nup358 J. Biol. Chem., February 8, 2002; 277(7): 4755 - 4763. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bellanger, C. Demeret, S. Goyat, and F. Thierry Stability of the Human Papillomavirus Type 18 E2 Protein Is Regulated by a Proteasome Degradation Pathway through Its Amino-Terminal Transactivation Domain J. Virol., August 15, 2001; 75(16): 7244 - 7251. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lassot, E. Ségéral, C. Berlioz-Torrent, H. Durand, L. Groussin, T. Hai, R. Benarous, and F. Margottin-Goguet ATF4 Degradation Relies on a Phosphorylation-Dependent Interaction with the SCF{beta}TrCP Ubiquitin Ligase Mol. Cell. Biol., March 15, 2001; 21(6): 2192 - 2202. [Abstract] [Full Text] |
||||
![]() |
A. M. Reimold, J. Kim, R. Finberg, and L. H. Glimcher Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice Int. Immunol., February 1, 2001; 13(2): 241 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Taylor, G. T. Furuta, K. Synnestvedt, and S. P. Colgan Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia PNAS, October 12, 2000; (2000) 220211797. [Abstract] [Full Text] |
||||
![]() |
S. Y. Fuchs, I. Tappin, and Z.'e. Ronai Stability of the ATF2 Transcription Factor Is Regulated by Phosphorylation and Dephosphorylation J. Biol. Chem., April 21, 2000; 275(17): 12560 - 12564. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Feuerstein, F. Chen, M. Madaio, M. Maldonado, and R. A. Eisenberg Induction of Autoimmunity in a Transgenic Model of B Cell Receptor Peripheral Tolerance: Changes in Coreceptors and B Cell Receptor-Induced Tyrosine-Phosphoproteins J. Immunol., November 15, 1999; 163(10): 5287 - 5297. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tintut, F. Parhami, V. Le, G. Karsenty, and L. L. Demer Inhibition of Osteoblast-specific Transcription Factor Cbfa1 by the cAMP Pathway in Osteoblastic Cells. UBIQUITIN/PROTEASOME-DEPENDENT REGULATION J. Biol. Chem., October 8, 1999; 274(41): 28875 - 28879. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Huggins, M. T. Chin, N. E. S. Sibinga, S.-L. Lee, E. Haber, and M.-E. Lee Characterization of the mUBC9-binding Sites Required for E2A Protein Degradation J. Biol. Chem., October 1, 1999; 274(40): 28690 - 28696. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Poukka, P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription J. Biol. Chem., July 2, 1999; 274(27): 19441 - 19446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Chakrabarti, R. Sood, S. Ganguly, S. Bohlander, Z. Shen, and G. Nucifora Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9 PNAS, June 22, 1999; 96(13): 7467 - 7472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Fuchs and Z.'e. Ronai Ubiquitination and Degradation of ATF2 Are Dimerization Dependent Mol. Cell. Biol., May 1, 1999; 19(5): 3289 - 3298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Rodriguez, C. Dargemont, and R. T. Hay SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting J. Biol. Chem., April 13, 2001; 276(16): 12654 - 12659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ivanova, S. V. Ivanov, A. Danilkovitch-Miagkova, and M. I. Lerman Regulation of STRA13 by the von Hippel-Lindau Tumor Suppressor Protein, Hypoxia, and the UBC9/Ubiquitin Proteasome Degradation Pathway J. Biol. Chem., April 27, 2001; 276(18): 15306 - 15315. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Taylor, G. T. Furuta, K. Synnestvedt, and S. P. Colgan Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia PNAS, October 24, 2000; 97(22): 12091 - 12096. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |